Sand Hill Global Advisors LLC Has $7.67 Million Position in Danaher Co. (NYSE:DHR)

Sand Hill Global Advisors LLC lessened its position in shares of Danaher Co. (NYSE:DHRFree Report) by 1.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,436 shares of the conglomerate’s stock after selling 347 shares during the quarter. Sand Hill Global Advisors LLC’s holdings in Danaher were worth $7,671,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. Moneta Group Investment Advisors LLC lifted its stake in shares of Danaher by 96,490.5% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 23,287,013 shares of the conglomerate’s stock valued at $6,180,839,000 after acquiring an additional 23,262,904 shares during the period. Geode Capital Management LLC lifted its stake in shares of Danaher by 14.3% during the fourth quarter. Geode Capital Management LLC now owns 12,774,623 shares of the conglomerate’s stock valued at $3,384,177,000 after acquiring an additional 1,595,344 shares during the period. Norges Bank acquired a new position in shares of Danaher during the fourth quarter valued at $2,057,164,000. Bank of New York Mellon Corp lifted its stake in shares of Danaher by 12.3% during the first quarter. Bank of New York Mellon Corp now owns 7,440,410 shares of the conglomerate’s stock valued at $1,875,281,000 after acquiring an additional 812,475 shares during the period. Finally, Amundi lifted its stake in shares of Danaher by 8.4% during the fourth quarter. Amundi now owns 4,852,751 shares of the conglomerate’s stock valued at $1,321,312,000 after acquiring an additional 375,805 shares during the period. Institutional investors and hedge funds own 76.71% of the company’s stock.

Insider Transactions at Danaher

In other news, SVP Daniel Raskas sold 11,213 shares of the company’s stock in a transaction dated Friday, July 28th. The stock was sold at an average price of $260.65, for a total transaction of $2,922,668.45. Following the completion of the transaction, the senior vice president now directly owns 38,288 shares of the company’s stock, valued at $9,979,767.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, SVP Jose-Carlos Gutierrez-Ramos sold 590 shares of the stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $250.54, for a total transaction of $147,818.60. Following the completion of the transaction, the senior vice president now directly owns 6,939 shares of the company’s stock, valued at $1,738,497.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Daniel Raskas sold 11,213 shares of the stock in a transaction that occurred on Friday, July 28th. The shares were sold at an average price of $260.65, for a total value of $2,922,668.45. Following the transaction, the senior vice president now directly owns 38,288 shares of the company’s stock, valued at $9,979,767.20. The disclosure for this sale can be found here. Insiders sold 47,922 shares of company stock valued at $12,552,233 over the last three months. Company insiders own 11.10% of the company’s stock.

Danaher Stock Down 2.5 %

DHR stock opened at $248.43 on Friday. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.08 and a quick ratio of 1.70. The stock has a market capitalization of $183.43 billion, a P/E ratio of 29.16, a P/E/G ratio of 2.77 and a beta of 0.80. The business has a 50-day moving average of $251.78 and a 200-day moving average of $245.04. Danaher Co. has a fifty-two week low of $221.22 and a fifty-two week high of $294.60.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings data on Tuesday, July 25th. The conglomerate reported $2.05 earnings per share for the quarter, topping the consensus estimate of $2.01 by $0.04. The company had revenue of $7.16 billion during the quarter, compared to analysts’ expectations of $7.12 billion. Danaher had a return on equity of 15.03% and a net margin of 20.95%. Danaher’s revenue for the quarter was down 7.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.76 earnings per share. On average, sell-side analysts anticipate that Danaher Co. will post 8.84 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently issued reports on DHR. Raymond James upped their price target on Danaher from $270.00 to $290.00 and gave the company an “outperform” rating in a research note on Wednesday, July 26th. StockNews.com initiated coverage on Danaher in a report on Monday, September 4th. They issued a “hold” rating for the company. Bank of America upped their price objective on Danaher from $250.00 to $280.00 in a report on Wednesday, July 26th. Royal Bank of Canada upped their price objective on Danaher from $260.00 to $292.00 in a report on Wednesday, July 26th. Finally, Stifel Nicolaus dropped their price objective on Danaher from $250.00 to $240.00 and set a “hold” rating for the company in a report on Wednesday, July 26th. Five equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average price target of $289.79.

Get Our Latest Report on DHR

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.